Sort   by:  
 Page size 
UnknownCOVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort study.
Not available
S-EPMC10278158 | biostudies-literature
UnknownCopy number architectures define treatment-mediated selection of lethal prostate cancer clones.
Not available
S-EPMC10415299 | biostudies-literature
Unknown<i>C9orf72</i> repeat expansion creates the unstable folate-sensitive fragile site FRA9A.
Not available
S-EPMC11632612 | biostudies-literature
UnknownInterleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
Not available
S-EPMC3367995 | biostudies-literature
UnknownThe Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial.
Not available
S-EPMC7359440 | biostudies-literature
UnknownIdentifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial.
Not available
S-EPMC12008128 | biostudies-literature
UnknownSotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Not available
S-EPMC10113515 | biostudies-literature
UnknownIdentification of seven new prostate cancer susceptibility loci through a genome-wide association study.
Not available
S-EPMC2846760 | biostudies-literature
UnknownDeterminants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.
Not available
S-EPMC8599450 | biostudies-literature
UnknownTrauma Association of Canada Annual Scientific Meeting, Westin Calgary Calgary, Alberta, Apr. 10–11, 2015
Not available
S-EPMC8186475 | biostudies-literature
Sort   by:  
 Page size